200 related articles for article (PubMed ID: 17661709)
1. Trastuzumab in CNS progressive metastatic breast cancer.
Tosoni A; Franceschi E; Esposti RD; Brandes AA
Future Oncol; 2007 Aug; 3(4):367-9. PubMed ID: 17661709
[No Abstract] [Full Text] [Related]
2. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
Gori S; Rimondini S; De Angelis V; Colozza M; Bisagni G; Moretti G; Sidoni A; Basurto C; Aristei C; Anastasi P; Crinò L
Oncologist; 2007 Jul; 12(7):766-73. PubMed ID: 17673608
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
4. Survival after brain metastases from breast cancer in the trastuzumab era.
Kirsch DG; Ledezma CJ; Mathews CS; Bhan AK; Ancukiewicz M; Hochberg FH; Loeffler JS
J Clin Oncol; 2005 Mar; 23(9):2114-6; author reply 2116-7. PubMed ID: 15774813
[No Abstract] [Full Text] [Related]
5. Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.
Metro G; Sperduti I; Russillo M; Milella M; Cognetti F; Fabi A
Oncologist; 2007 Dec; 12(12):1467-9; author reply 1469-71. PubMed ID: 18165625
[No Abstract] [Full Text] [Related]
6. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer.
Altundag K; Altundag O; Atik MA; Morandi P; Gunduz M
Breast; 2005 Oct; 14(5):425. PubMed ID: 16216749
[No Abstract] [Full Text] [Related]
7. Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?
Tosoni A; Franceschi E; Brandes AA
Crit Rev Oncol Hematol; 2008 Dec; 68(3):212-21. PubMed ID: 18550383
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu expression in primary and metastatic breast cancer.
Lower EE; Glass E; Blau R; Harman S
Breast Cancer Res Treat; 2009 Jan; 113(2):301-6. PubMed ID: 18273700
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase predicts trastuzumab responsiveness in metastatic breast cancer.
Yamashita J; Akizuki M; Jotsuka T; Harao M; Nakano S
Breast J; 2006; 12(3):288. PubMed ID: 16684339
[No Abstract] [Full Text] [Related]
10. Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer.
Kurosumi M
Breast Cancer; 2009; 16(4):283. PubMed ID: 19756922
[No Abstract] [Full Text] [Related]
11. [Brain metastases in breast cancer: a special disease course for HER2 positive tumors].
Hurkens KP; Hupperets PS; Creemers GJ; Erdkamp FL; van de Vijver KK; Tjan-Heijnen VC
Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2701-6. PubMed ID: 19192581
[TBL] [Abstract][Full Text] [Related]
12. HER2/neu role in breast cancer: from a prognostic foe to a predictive friend.
Ferretti G; Felici A; Papaldo P; Fabi A; Cognetti F
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):56-62. PubMed ID: 17218853
[TBL] [Abstract][Full Text] [Related]
13. HER2 status and benefit from adjuvant trastuzumab in breast cancer.
Paik S; Kim C; Wolmark N
N Engl J Med; 2008 Mar; 358(13):1409-11. PubMed ID: 18367751
[No Abstract] [Full Text] [Related]
14. Current perspective - trastuzumab.
Hall PS; Cameron DA
Eur J Cancer; 2009 Jan; 45(1):12-8. PubMed ID: 19042123
[TBL] [Abstract][Full Text] [Related]
15. Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
Abrey LE
Nat Clin Pract Neurol; 2006 Jun; 2(6):302-3. PubMed ID: 16932571
[No Abstract] [Full Text] [Related]
16. The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review.
Tokuda Y; Suzuki Y; Saito Y; Umemura S
Breast Cancer; 2009; 16(4):295-300. PubMed ID: 19609647
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases in patients receiving trastuzumab for breast cancer.
Errante D; Bernardi D; Bianco A; Salvagno L
Neurol Sci; 2007 Mar; 28(1):52-3. PubMed ID: 17385098
[No Abstract] [Full Text] [Related]
18. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M
Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab in the treatment of breast cancer.
Hortobagyi GN
N Engl J Med; 2005 Oct; 353(16):1734-6. PubMed ID: 16236745
[No Abstract] [Full Text] [Related]
20. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.
Grossi PM; Ochiai H; Archer GE; McLendon RE; Zalutsky MR; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2003 Nov; 9(15):5514-20. PubMed ID: 14654531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
